ResMed, Inc.
http://www.resmed.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From ResMed, Inc.
ResMed Lays Off 5% Of Work Force Amid Strong First-Quarter Results For Fiscal Year 2024
ResMed’s reported a 16% rise in first-quarter fiscal year sales and 5% cut of its workforce amid restructuring of parts of its business.
Novo Nordisk heeds KBP Biosciences’ CLARION call
Novo Nordisk’s metabolic juggernaut semaglutide is known to work in chronic kidney disease – but the group appears to want a back-up plan.
Medtech DEI Experts Talk Shop: ‘It’s Going To Transform Businesses’
An all-female panel of medtech DEI leaders at the LSX Congress USA conference discussed the importance of diversity and inclusion in research, clinical trials, product development and services to advance health equity as well as fundamental business goals.
Swiss R&D Innovation: A Tale Of Two Firms Developing Cell Therapies For Wounds
While perhaps best known for historical achievements in immuno-oncology and CNS disorders, the Swiss biotech sector is slowly cultivating a new area of expertise in dermatology. Scrip spoke with two firms applying cell therapy technologies to the challenging area of chronic and acute wounds.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
-
- CareTouch
- Curative Medical, Inc.
- HB Healthcare
- HEALTHCAREfirst
- Inova Labs, Inc.
- Jaysec Technologies LLC
- Laboratories Narval
- Maribo Medico
- MatrixCare
- Mediserv
- Propeller Health
- SleepScore Labs, Umbian
- Unimedis
- Brightree LLC.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice